Xiang Ao

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Signaling Pathway

Magnetic Resonance

Chemotherapy Induced

Risk Assessment

Top Venues

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Ni Qiu, Huan Jin, Lulu Cui, Yong-Tao Zhan, Hao-Ming Xia, Ming Jiang, Jie Zhou, Hong-Ling Liang, Xiang Ao, Zhi-Min He, Hong-Sheng Li
IFT20 Confers Paclitaxel Resistance by Triggering β-arrestin-1 to Modulate ASK1 Signaling in Breast Cancer. Molecular cancer research : MCR 21 (3) (2023)
Ni Qiu, Huan Jin, Lulu Cui, Yong-Tao Zhan, Hao-Ming Xia, Ming Jiang, Jie Zhou, Hong-Ling Liang, Xiang Ao, Zhi-Min He, Hong-Sheng Li
IFT20 Confers Paclitaxel Resistance by Triggering β-arrestin-1 to Modulate ASK1 Signaling in Breast Cancer. Molecular cancer research : MCR 21 (3) (2023)
Ni Qiu, Huan Jin, Lulu Cui, Yong-Tao Zhan, Hao-Ming Xia, Ming Jiang, Jie Zhou, Hong-Ling Liang, Xiang Ao, Zhi-Min He, Hong-Sheng Li
IFT20 confers paclitaxel resistance by triggering β-arrestin-1 to modulate ASK1 signaling in breast cancer. Molecular cancer research : MCR (2022)